Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. The Richline Group Inc
WARNING LETTER
•The Richline Group Inc•April 16, 2025

The Richline Group Inc – FDA Warning Letter, Apr 16, 2025

Record Details

The FDA issued a Warning Letter to The Richline Group, Inc. following an inspection of their Tamarac, FL facility from March 24 to April 16, 2025. The inspection identified significant, including repeat, violations of the Food, Drug, and Cosmetic Act related to the firm’s Inverness Ear Care Antiseptic, Inverness Ear Care Solution, and Inverness Home Ear Piercing Kit products. A primary violation cited the firm for marketing the Ear Care Antiseptic and Ear Care Solution without required marketing authorization. Depending on product claims, these products are regulated either as medical devices requiring a 510(k) clearance or Premarket Approval (PMA), or potentially as drugs needing an approved new drug application. Without such authorization, the products are deemed adulterated and misbranded. Additionally, the inspection revealed violations of the Quality System Regulation (21 CFR Part 820), rendering the products adulterated. Specifically, The Richline Group failed to establish and maintain adequate design control procedures (21 CFR 820.30(a)) for its products, lacking essential design documentation and proper validation for product expiration dates. The FDA requires the firm to obtain proper marketing authorization for its products and implement a compliant quality system, particularly addressing the deficiencies in design controls and stability testing. The firm"s prior responses regarding these observations were deemed insufficient.

Company
The Richline Group Inc
Inspection date
April 16, 2025
Product type
Other
Office
Center for Devices and Radiological Health
Person
  • Matthew G. Hillebrenner
View Company Profile

ID · f7c35294-420f-4ed0-bcdc-033c8a38d115

Violation Codes10
21 CFR 820.30(a)21 CFR 82021 CFR 820.90(a)21 CFR 803.12(a)FD&C Act 502(o)21 U.S.C. 352(o)FD&C Act 501(f)(1)(B)21 U.S.C. 351(f)(1)(B)FD&C Act 515(a)21 U.S.C. 360e(a)

Full citation text and observation details available on the Dashboard.

Other documents for The Richline Group Inc
  • 483 - 2025-04-16April 16, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore The Richline Group Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.